VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 901–1,000 of 1,013
Aberrant Receptor Signaling and Trafficking as Mechanisms in Oncogenesis
Rusten, T. E., Haglund, K., & Stenmark, H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i1.20 · Cited by 58
Wang, F., Liu, S., Xi, S., Yan, L., Wang, H. H., Song, Y., & Sun, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.08.008 · Cited by 49
“HIF-1 directly activates VEGF and VEGF receptor (VEGFR-1) transcription by binding to HRE, and plays an important role during normal growth and tumor formation (Forsythe et al., 1996; Olsson et al., 2006).”
BackgroundFan, W., Sun, D., Liu, J., Dong, L., Wang, Y., Narsinh, K. H., Li, Y., Qin, X., Liang, J., Tian, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045621 · Cited by 52
“Engrafted mADSCs activated VEGFR2, which can mediate mitogenic signaling to elicit angiogenic response and further, to functionally compensate for ischemia in the cardiovascular system [34,35].”
BackgroundStudy of normal and pathological blood vessel morphogenesis in Flt1‐tdsRed BAC Tg mice
Matsumoto, K., Azami, T., Otsu, A., Takase, H., Ishitobi, H., Tanaka, J., Miwa, Y., Takahashi, S., & Ema, M. (2012) · genesis · doi:10.1002/dvg.22031 · Cited by 50
“The VEGF family consists of VEGF-A, B, C, D and placental growth factor (PIGF) (Olsson et al., 2006).”
BackgroundBlocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells
Montenegro, C. F., Pontes, C. L. S., Ribeiro, J. U., Machado, A. Z., Ramos, R. F., Figueiredo, C. C., Morandi, V., & Selistre-de-Araújo, H. S. (2012) · Biochimie · doi:10.1016/j.biochi.2012.04.020 · Cited by 59
Sisto, M., Lisi, S., Lofrumento, D. D., D’Amore, M., Frassanito, M. A., & Ribatti, D. (2012) · Genes and Immunity · doi:10.1038/gene.2012.9 · Cited by 49
Sunshine, S. B., Dallabrida, S. M., Durand, E. M., Ismail, N. S., Bazinet, L. F., Birsner, A. E., Sohn, R. L., Ikeda, S., Pu, W. T., Kulke, M. H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203275109 · Cited by 49
“VEGF stimulates endothelial NO synthase (eNOS), resulting in NO production and lower BP (21, 22).”
BackgroundYuan, J., Guo, Q., Qureshi, A. R., Anderstam, B., Eriksson, M., Heimbürger, O., Barany, P. F., Stenvinkel, P., & Lindholm, B. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft256 · Cited by 51
“sVEGFR-1 is likely to be a negative regulator of VEGF availability, or may prolong the different VEGF activities [4].”
BackgroundJi, Y., Chen, S., Li, K., Xiao, X., Xu, T., & Zheng, S. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12592 · Cited by 53
Filippi, L., Monte, M. D., Casini, G., Daniotti, M., Sereni, F., & Bagnoli, P. (2014) · Medicinal Research Reviews · doi:10.1002/med.21336 · Cited by 51
A fluidic device to study directional angiogenesis in complex tissue and organ culture models
Barkefors, I., Thorslund, S., Nikolajeff, F., & Kreuger, J. (2009) · Lab Chip · doi:10.1039/b814691h · Cited by 48
Self-citationFaes, S., Uldry, É., Planche, A., Santoro, T., Pythoud, C., Demartines, N., & Dormond, O. (2016) · Oncotarget · doi:10.18632/oncotarget.13323 · Cited by 54
“VEGF possesses three major receptors VEGFR-1, VEGFR-2 and VEGFR-3, with VEGFR-3 acting mostly on lymphatic endothelial cells [23].”
BackgroundWang, Z., Jin, C., Li, X., & Ding, K. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.11.091 · Cited by 51
Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK
Genetos, D. C., Wong, A., Watari, S., & Yellowley, C. E. (2010) · Bone · doi:10.1016/j.bone.2010.08.024 · Cited by 51
“[33]).”
Mechanosensitive Ion Channels and Their Role in Cancer Cells
Karska, J., Kowalski, S., Saczko, J., Moisescu, M. G., & Kulbacka, J. (2023) · Membranes · doi:10.3390/membranes13020167 · Cited by 48
Zeng, J., Deng, Q., Chen, Z., Yan, S., Dong, Q., Zhang, Y., Yuan, C., Li, L., He, Y., & Shi, J. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107278 · Cited by 48
Ravichandran, R., Venugopal, J. R., Mukherjee, S., Sundarrajan, S., & Ramakrishna, S. (2015) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0265 · Cited by 48
“VEGF plays a key role in both vasculogenesis and angiogenesis 8,9 and also therapies with VEGF for the treatment of ischemic diseases have attracted great attention.”
Fibromodulin Enhances Angiogenesis during Cutaneous Wound Healing
Zheng, Z. S., Jia, J., Velasco, O., Hsu, C., Zhang, K., Levin, A., Murphy, M. C., Zhang, X., Ting, K., & Soo, C. B. (2014) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000243 · Cited by 48
Jacobson, O., & Chen, X. S. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007625 · Cited by 50
“Under hypoxic conditions, the expression levels of VEGF-A and its receptors VEGFR-1 and -2 are dramatically upregulated (Olsson et al., 2006).”
BackgroundLiang, X., Zhang, J.-Q., Liu, Z., Zhang, J., Yan, J., Jin, Y., & Lin, J. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob40368h · Cited by 50
Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients
Murugeswari, P., Shukla, D., Ramasamy, K., Namperumalsamy, P., Stitt, A. W., & Muthukkaruppan, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107551 · Cited by 50
“Consequently, the endothelial cell proliferation, migration, permeability and vascular assembly are inhibited by RZB [33], [34], [35].”
BackgroundFilant, J., DeMayo, F. J., Pru, J. K., Lydon, J. P., & Spencer, T. E. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.114496 · Cited by 46
Ginsenoside Rh2 inhibits vascular endothelial growth factor‐induced corneal neovascularization
Zhang, X., Li, K., Yu, Q., Yao, M., Ge, H., Li, X., Jiang, Q. L., Yao, J., & Cao, C. (2018) · The FASEB Journal · doi:10.1096/fj.201701074rr · Cited by 48
“Activation of downstream signaling pathways, including the PI3K-AKT and ERK-MAPK, is required for VEGFinduced endothelial cell proliferation and vascular formation (27, 28).”
BackgroundComputer Simulation of TSP1 Inhibition of VEGF–Akt–eNOS: An Angiogenesis Triple Threat
Bazzazi, H., Zhang, Y., Jafarnejad, M., Isenberg, J. S., Annex, B. H., & Popel, A. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00644 · Cited by 51
“…leads to the activation of downstream signaling pathways including ERK1/2 and PI3K/Akt that induce cellular proliferation, survival, motility, and enhanced vascular permeability (Olsson et al., 2006; Dellinger and Brekken, 2011; Simons et al., 2016), the dominant pathway in post-natal angiogenesis.”
BackgroundGuarnaccia, L., Navone, S. E., Trombetta, E., Cordiglieri, C., Cherubini, A., Crisà, F. M., Rampini, P. M., Miozzo, M. R., Fontana, L., Caroli, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27116-7 · Cited by 51
Binding and Structural Properties of DNA Aptamers with VEGF-A-Mimic Activity
Yoshitomi, T., Hayashi, M., Oguro, T., Kimura, K. B., Wayama, F., Furusho, H., & Yoshimoto, K. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.034 · Cited by 48
“INTRODUCTION Vascular endothelial growth factors (VEGFs) are hypoxia-inducible secreted proteins to promote angiogenesis.(1) Among them, VEGF-A is the major contributor to physiological and pathological angiogenesis.”
BackgroundInhibition of Breast Cancer Cell Growth and Invasiveness by Dual Silencing of HER-2 and VEGF
Tai, W., Qin, B., & Cheng, K. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002514 · Cited by 48
Gratzinger, D. A., Advani, R. H., Zhao, S., Talreja, N., Tibshirani, R. J., Shyam, R., Horning, S. J., Sehn, L. H., Farinha, P., Briones, J., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07942.x · Cited by 48
“Both VEGFR1 and VEGFR2 are activated following VEGF ligand binding resulting in intracellular signalling events; tyrosine phosphorylation of VEGFR2 following its activation is strong and immunohistochemically detectable (Olsson et al, 2006).”
BackgroundUps and Downs of Guided Vessel Sprouting: The Role of Polarity
Lee, C. Y., & Bautch, V. L. (2011) · Physiology · doi:10.1152/physiol.00018.2011 · Cited by 53
Directing human embryonic stem cell differentiation by non-viral delivery of siRNA in 3D culture
Zoldan, J., Lytton-Jean, A. K. R., Karagiannis, E. D., Deiorio-Haggar, K., Bellan, L. M., Langer, R., & Anderson, D. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.057 · Cited by 47
“KDR is the receptor for VEGF, an essential component in blood vessel vasculogenesis and angiogenesis [33] It regulates vascular endothelial proliferation, migration, survival and increased permeability through intracellular signaling cascades, including the PI3K pathway(reviewed in [34] and [35]).”
BackgroundLu, H., Yuan, P., Ma, X., Jiang, X., Liu, S., Ma, C., Philipsen, S., Zhang, Q., Yang, J., Xu, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36409-z · Cited by 50
“VEGF signaling is a key driver of EC migration, proliferation, and capillary tube formation, primarily through VEGFR2 51 .”
InfluentialDICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling
Han, S. W., Jung, Y., Lee, E., Park, H., Kim, G.-W., Jeong, J., Han, M. S., & Choi, J. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt019 · Cited by 49
Maher, T. M., Molyneaux, P. L., & Woodcock (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s38833 · Cited by 52
“39 VEGF is a critical mediator of angiogenesis which drives endothelial cell proliferation and vessel formation predominantly through VEGFR-2.”
Shi, L., Wu, T.-T., Wang, Z., Xue, J., & Xu, Y. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.071 · Cited by 47
Woad, K. J., Hunter, M. G., Mann, G. E., Laird, M., Hammond, A. J., & Robinson, R. S. (2011) · Reproduction · doi:10.1530/rep-11-0277 · Cited by 53
“VEGF ligands bind to three receptors, namely VEGFR1, VEGFR2 and VEGFR3 (Cebe-Suarez et al. 2006, Olsson et al. 2006).”
BackgroundChen, G., Xu, X., Zhang, L., Fu, Y., Wang, M., Gu, H., & Xie, X. (2014) · Cell Research · doi:10.1038/cr.2014.112 · Cited by 49
Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
Collet, G., Lamerant‐Fayel, N., Tertil, M., Hafny‐Rahbi, B. E., Stępniewski, J., Guichard, A., Foucault‐Collet, A., Klimkiewicz, K., Pètoud, S., Matejuk, A., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0637 · Cited by 48
“surface upon hypoxia (Figure 2C top, d, e) while VEGFR3 was absent in both conditions (Figure 2C top, c, f) (38).”
Shi, S., Kanasaki, K., & Koya, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.154 · Cited by 53
“13 Sitagliptin exerts no influence on integrin β1 or VEGF-R1 levels in endothelial cells VEGF-A serves biologically significant roles throug h the VEGF-receptor (-R) 2 in endothelial cells, and VEGF-A binding to VEGF-R1 ex erts a dominant negative effect on VEGF-A-mediated survival signaling of endothelial c e ls [17].”
BackgroundEndothelial Cell Response to Fusobacterium nucleatum
Mendes, R. T., Nguyen, D., Stephens, D. N., Pamuk, F., Fernandes, D., Dyke, T. E. V., & Kantarcı, A. (2016) · Infection and Immunity · doi:10.1128/iai.01305-15 · Cited by 47
“Since VEGF is associated with vessel growth and angiogenesis (48), these data are in accordance with the proliferation and tube formation data shown in Fig.”
ResultMutually Supportive Mechanisms of Inflammation and Vascular Remodeling
Whiteford, J. R., Rossi, G. D., & Woodfin, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.001 · Cited by 55
An update on the diagnosis and management of the polyneuropathy of POEMS syndrome
Cerri, F., Falzone, Y., Riva, N., & Quattrini, A. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9068-4 · Cited by 47
Yang, Z., Chen, G., Cui, Y., Xiao, G., Su, T., Yu, J., Zhang, Z., Han, Y., Yang, K., & Jin, L. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1529099 · Cited by 47
“The phosphorylation of specific sites generates binding sites for the SH2 domains of various signaling molecules and has subsequent effects of cell proliferation, migration, permeability, and survival on the vascular endothelium.(15) In contrast, antiangiogenic agents that inhibit VEGFR-2 and block VEGF-stimulated end…”
Gao, J., Hu, H., & Wang, X. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03815-4 · Cited by 47
“1 3 In line with the previous publication [26], VEGF increased p-VEGFR2 (T951) and (T1175) levels in HUVEC (Fig.”
BackgroundDıkıcı, S., Dikici, B. A., Bhaloo, S. I., Balcells, M., Edelman, E. R., MacNeil, S., Reilly, G. C., Sherborne, C., & Claeyssens, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00451 · Cited by 47
“ECs are sensitive to VEGF signaling, which regulates their proliferation, migration and survival (Olsson et al., 2006; Wang et al., 2008).”
BackgroundRossi, G. D., Vähätupa, M., Cristante, E., Liyanage, S. E., May, U., Pellinen, L., Aittomäki, S., Córdova, Z. M., Pesu, M., Järvinen, T. A. H., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.315941 · Cited by 52
Endothelial cell activation in a VEGF-A gradient: Relevance to cell fate decisions
Akeson, A. L., Herman, A. M., Wiginton, D., & Greenberg, J. M. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.02.001 · Cited by 51
Hare, L., Schwarz, Q., Wiszniak, S., Gurung, R., Montgomery, K. G., Mitchell, C. A., & Phillips, W. A. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.04.022 · Cited by 47
Tian, F., Zhu, C.-H., Zhang, X., Xie, X., Xin, X., Yi, Y., Lin, L., Geng, M., & Ding, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036350 · Cited by 51
“Among the various proangiogenic factors that have been identified, vascular endothelial growth factor and its cognate receptor vascular endothelial growth factor-2/KDR play a major role in tumor angiogenesis (Olsson et al., 2006).”
BackgroundWei, Q., Zhang, F., Richardson, M. M., Roy, N. H., Rodgers, W., Liu, Y., Zhao, W., Fu, C., Ding, Y., Huang, C., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011096 · Cited by 52
Restin, T., Kajdi, M.-E., Schläpfer, M., Z’graggen, B. R., Booy, C., Dumrese, C., & Beck‐Schimmer, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184973 · Cited by 46
“Particularly in brain injury, this early phase of brain edema formation involves an increase of vascular endothelial growth factor (VEGF) [5], one of the most potent permeability factors [6] [7].”
BackgroundCurrent Knowledge and Future Therapeutic Prospects in Symptomatic Intervertebral Disc Degeneration
Kim, J. H., Ham, C. H., & Kwon, W. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.3.199 · Cited by 51
“Under hypoxic conditions, which is the normal environment for the inner part of the IVDs, VEGF expression is initiated and regulated by HIF-1 regulation and acts as the critical step initiating vascular ingrowth.(36,80) IL-8 expression exhibits a similar response to inflammatory stimulation under hypoxic conditions an…”
BackgroundEffect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
Lassoued, W., Murphy, D. A., Tsai, J. H., Oueslati, R., Thurston, G., & Lee, W. M. F. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14009 · Cited by 46
“VEGF signals through its receptors, primarily VEGFR2 (FLK-1/KDR), to regulate multiple facets of tumor angiogenesis.(4-6) Its expression is often upregulated in tumor cells due to the activation of oncogenes and inactivation of tumor suppressor gene during neoplastic transformation (CITE).”
BackgroundCai, J., Chen, Z., Ruan, Q., Han, S., Liu, L., Qi, X., Boye, S. L., Hauswirth, W. W., Grant, M. B., & Boulton, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.296590 · Cited by 46
ALS and Oxidative Stress: The Neurovascular Scenario
Anand, A., Thakur, K., & Gupta, P. K. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/635831 · Cited by 47
“Recent evidence from studies also indicates that neural cells are directly affected by VEGF-A, VEGF-B and VEGF-C [35].”
BackgroundFleetwood, F., Klint, S., Hanze, M., Gunneriusson, E., Frejd, F. Y., Ståhl, S., & Löfblom, J. (2014) · Scientific Reports · doi:10.1038/srep07518 · Cited by 48
Zhang, J., Li, L., Li, J., Liu, Y., Zhang, C., Zhang, Y., & Zen, K. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304705 · Cited by 47
“As a potent proangiogenic factor specific for vascular endothelial cells, VEGFR2 plays an essential role in promoting endothelial cell angiogenesis, including cell proliferation, migration, and tube formation.(40,41) The activation of VEGFR2 by phosphorylation on its Tyr1157 will activate multiple signaling enzymes, i…”
BackgroundIL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis
Yang, T., Lin, Q., Zhao, M., Hu, Y., Yu, Y., Jin, J., Zhou, H., Hu, X., Wei, R., Zhang, X., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306543 · Cited by 48
“IL-37 Activates Survival Signals in ECs To understand the signaling events induced by IL-37, we examined the major endothelial survival signals, including the extracellular signal-regulated kinase 1/2 (ERK1/2) and the serine–threonine kinase AKT, which are crucial for EC proliferation, survival, and migration.(19,20)…”
BackgroundResultAlonso, F., Domingos‐Pereira, S., Gal, L. L., Derré, L., Meda, P., Jichlinski, P., Nardelli‐Haefliger, D., & Haefliger, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7370 · Cited by 48
“Under these conditions, VEGF and its receptor, which are main inducers of angiogenesis [3], were unchanged.”
BackgroundReceptor Tyrosine Kinases: Structure, Functions and Role in Human Disease
Yarden, Y., & Wheeler, D. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-2053-2 · Cited by 45
LeBlanc, N. J., Guruswamy, R., & ElAli, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0478-6 · Cited by 54
“While some reports have suggested that VEGFR-1 is expressed in motor neurons, endothelial cells, and astrocytes [18], other reports showed different expression pattern [9, 47].”
InfluentialEndothelium originated from colorectal cancer stem cells constitute cancer blood vessels
Shangguan, W., Fan, C., Chen, X., Lu, R., Liu, Y., Li, Y., Shang, Y., Yin, D., Zhang, S., Huang, Q., et al. (2017) · Cancer Science · doi:10.1111/cas.13262 · Cited by 45
Pro-angiogenic peptides in biomedicine
Rosa, L. D., Stasi, R. D., & D’Andrea, L. D. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.010 · Cited by 46
Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics
Bui, K., & Hong, Y. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.597374 · Cited by 48
Notch Signaling in Ocular Vasculature Development and Diseases
Dou, G., Wang, L., Wang, Y., & Han, H. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00256 · Cited by 46
Gonçalves, V., Gautier, B., Garbay, C., Vidal, M., & Inguimbert, N. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.03.027 · Cited by 46
“VEGF165 pro-angiogenic activity is mediated through binding to two high-affinity tyrosine kinase receptors: VEGF receptor 1 (VEGF-R1, Flt-1) and VEGF receptor 2 (VEGF-R2, KDR), located predominantly at the surface of endothelial cells but also on several tumour cell lines [3].”
BackgroundBasile, A. M., Gatto, A. D., Diana, D., Stasi, R. D., Falco, A., Festa, M., Rosati, A., Barbieri, A., Franco, R., Arra, C., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101435r · Cited by 46
Thulin, Å., Ringvall, M., Dimberg, A., Kårehed, K., Väisänen, T., Väisänen, M., Hamad, O. A., Wang, J., Bjerkvig, R., Nilsson, B., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0094 · Cited by 49
“The most well known proangiogenic factor to date is vascular endothelial growth factor (VEGF), which is required for the development of a vascular system during embryogenesis and is also a central regulator of adult neovascularization (2).”
BackgroundSelf-citationVEGF-A engages at least three tyrosine kinases to activate PI3K/Akt
Ruan, G.-X., & Kazlauskas, A. (2012) · Cell Cycle · doi:10.4161/cc.20535 · Cited by 46
Elkaeed, E. B., Yousef, R. G., Elkady, H., Mehany, A. B. M., Alsfouk, B. A. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2127907 · Cited by 45
le Noble, F. A. C., Mourad, J., Levy, B. I., & Struijker-Boudier, H. A. J. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19427 · Cited by 53
Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks
Kumbhar, P., Kolekar, K. A., Vishwas, S., Shetti, P. P., Kumbar, V., Pinto, T. D. J. A., Paiva‐Santos, A. C., Veiga, F., Gupta, G., Singh, S. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102322 · Cited by 46
Bai, Y., Liang, S., Yu, W., Zhao, M., Huang, L., Zhao, M., & Li, X. (2014) · PubMed Central · Cited by 55
Molecular pathogenesis and therapeutic strategies of human osteosarcoma
Denduluri, S. K., Wang, Z., Yan, Z., Wang, J., Wei, Q., Mohammed, M. K., Haydon, R. C., Luu, H. H., & He, T. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.29.20150075 · Cited by 45
Peng, F.-W., Wu, T.-T., Ren, Z., Xue, J., & Shi, L. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.006 · Cited by 48
Pan, W., Pham, V. N., Stratman, A. N., Castranova, D., Kamei, M., Kidd, K. R., Lo, B. D., Shaw, K. M., Torres-Vazquez, J., Mikelis, C. M., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408328 · Cited by 44
Meeting the biologic challenge of colorectal metastases
Wanebo, H. J., LeGolvan, M. P., Paty, P. B., Saha, S., Zuber, M., D'Angelica, M. I., & Kemeny, N. E. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9517-x · Cited by 50
Gautier, B., Miteva, M. A., Gonçalves, V., Huguenot, F., Coric, P., Bouaziz, S., Seijo, B., Gaucher, J., Broutin, I., Garbay, C., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.10.016 · Cited by 47
Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking
Tan, W. H., Popel, A. S., & Gabhann, F. M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.015 · Cited by 54
“Upon ligation, the cytoplasmic tails of the two VEGFR2 monomers phosphorylate each other on residues Y1175, Y1214, and other tyrosine sites [19].”
BackgroundGene Expression Analysis in Human Breast Cancer Associated Blood Vessels
Jones, D. T., Lechertier, T., Mitter, R., Herbert, J. M. J., Bicknell, R., Jones, J. L., Li, J., Buffa, F. M., Harris, A. L., & Hodivala‐Dilke, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044294 · Cited by 45
“Angiogenesis is influenced by several growth factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) [3,4].”
Matozaki, T., Murata, Y., Mori, M., Kotani, T., Okazawa, H., & Ohnishi, H. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.001 · Cited by 50
Tirumani, S. H., Fairchild, A., Krajewski, K. M., Nishino, M., Howard, S. A. H., Baheti, A., Rosenthal, M. H., Jagannathan, J. P., Shinagare, A. B., & Ramaiya, N. H. (2015) · Radiographics · doi:10.1148/rg.352140119 · Cited by 45
Escudero, C., Celis, C., Sáez, T., Martín, S. S., Valenzuela, F. J., Aguayo, C. R., Bertoglia, P., Roberts, J. M., & Acurio, J. (2014) · Placenta · doi:10.1016/j.placenta.2014.01.007 · Cited by 46
“This receptor has potent tyrosine kinase activity and transduces the major signals for angiogenesis [25,26].”
BackgroundInfluentialClinical application of genetics to guide prevention and treatment of oral diseases
Kornman, K. S., & Polverini, P. J. (2014) · Clinical Genetics · doi:10.1111/cge.12396 · Cited by 45
Enjuanes, A., Benavente, Y., Hernández‐Rodríguez, J., Queralt, C., Yagüe, J., Jares, P., de Sanjosé, S., Campo, E., & Cid, M. C. (2012) · Rheumatology · doi:10.1093/rheumatology/ker429 · Cited by 50
Favia, A., Pafumi, I., Desideri, M., Padula, F., Montesano, C., Passeri, D., Nicoletti, C., Orlandi, A., Bufalo, D. D., Sergi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep18925 · Cited by 45
Emerging molecular basis of hematogenous metastasis in gastric cancer
Zhong, J., Chen, Y., & Wang, L.-J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2434 · Cited by 46
Identification of signalling cascades involved in red blood cell shrinkage and vesiculation
Kostova, E., Beuger, B. M., Klei, T. R. L., Halonen, P., Lieftink, C., Beijersbergen, R. L., van den Berg, T. K., & van Bruggen, R. (2015) · Bioscience Reports · doi:10.1042/bsr20150019 · Cited by 49
The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and function
Baimukanova, G., Miyazawa, B. Y., Potter, D. R., Gibb, S. L., Keating, S. M., Danesh, A., Beyer, A. I., Dayter, Y., Bruhn, R. L., Muench, M. O., et al. (2016) · Transfusion · doi:10.1111/trf.13455 · Cited by 45
“This soluble receptor has the ability to inhibit VEGF-induced vascular permeability, edema, and inflammation, by binding free circulating VEGF.55,56 Although not investigated in these studies, another factor known to be released by extended storage of PLTs is PLTactivating factor.”
BackgroundNovel hypoxia-targeting Pt( iv ) prodrugs
Xu, Z., Zhao, J., Gou, S.-H., & Xu, G. (2017) · Chemical Communications · doi:10.1039/c7cc01320e · Cited by 46
Novel Systemic Therapies for Advanced Gastric Cancer
Kim, H. J., & Oh, S. C. (2018) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2018.18.e3 · Cited by 46
“Among these receptors, VEGFR2 is the main effector of RTK and mediates downstream signaling cascades, including the phospholipase C-γ-protein kinase C-MEK-MAPK pathway and PI3K-Akt-endothelial nitric oxide synthase pathway [46,49,50].”
BackgroundA FRESH Take on Resolution in 3D Bioprinting
Corbett, D. C., Olszewski, E., & Stevens, K. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.09.003 · Cited by 43
Jumonji domain‐containing protein 6 protein and its role in cancer
Yang, J., Chen, S., Yang, Y., Ma, X., Shao, B., Yang, S., Wei, Y., & Wei, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12747 · Cited by 48
Yang, Q., Ni, L., İmani, S., Xiang, Z., Hai, R., Ding, R., Fu, S., Wu, J., & Wen, Q. (2020) · Cancer Management and Research · doi:10.2147/cmar.s252181 · Cited by 45
Zhong, J., Ali, A. N., Voloschin, A. D., Liu, Y., Curran, W. J., CROCKER, I. R., & Shu, H. G. (2014) · Cancer · doi:10.1002/cncr.29234 · Cited by 45
Sui, W., Zhang, Y., Wang, Z., WANG, Z., Jia, Q., Wu, L., & Zhang, W. (2014) · Oncology Reports · doi:10.3892/or.2014.3093 · Cited by 46
“The activation of the PI3K/ AKT/mTOR signaling pathway in endothelial cells promotes their survival when cultured in vitro (31) and in the tumor vasculature in vivo (32).”
BackgroundPEDF and VEGF-A Output from Human Retinal Pigment Epithelial Cells Grown on Novel Microcarriers
Falk, T., Congrove, N. R., Zhang, S., McCourt, A. D., Sherman, S. J., & McKay, B. S. (2012) · BioMed Research International · doi:10.1155/2012/278932 · Cited by 48
“Both of these molecules have been extensively studied with regard to their role in controlling tissue vascularity, where they have opposing effects to either, respectively, inhibit or promote angiogenesis [16, 17, 26].”
BackgroundInfluentialNetrin-4 Acts as a Pro-angiogenic Factor during Zebrafish Development
Lambert, E., Coissieux, M., Laudet, V., & Mehlen, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289371 · Cited by 45
“endothelial cell surface and, upon ligand binding, trigger downstream signaling, including activation of the mitogen-activated protein kinase (MAPK) pathway, phosphoinositide kinase-3 (PI3K) andAkt pathway, phospholipase C , and small GTPases such as Rac1 (12, 13).”
BackgroundSuarez, S., McCollum, G. W., Bretz, C. A., Yang, R., Capozzi, M. E., & Penn, J. S. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14217 · Cited by 47
Effects and action mechanisms of individual cytokines contained in PRP on osteoarthritis
Wang, Z., Zhu, P., Liao, B., You, H., & Cai, Y. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04119-3 · Cited by 48
“D [64, 65].”
Shi, G., Chen, J., Zhang, C., Zhao, X., Wang, J., Chen, R., Xu, R., Song, D., & Zhang, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22800 · Cited by 46
“The association of VEGF and its receptor initiates a series of downstream signaling cascades to promote angiogenesis [40].”
Background
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.